40
Participants
Start Date
May 1, 2017
Primary Completion Date
January 31, 2022
Study Completion Date
January 31, 2022
Subcutaneous immunotherapy with ALK Alutard birch or ALK Alutard timothy
According to standardized clinical protocol
No immunotherapy, symptomatic treatment
These patients will only receive symptomatic treatment for their allergic rhinoconjunctivitis.
Karolinska University Hospital, Stockholm
Karolinska Institutet
OTHER